Portal Vein Thrombosis Recruiting Phase 3 Trials for Rivaroxaban (DB06228)

Also known as: Portal (vein) obstruction / Pylethrombosis / Thrombosis portal vein

IndicationStatusPhase
DBCOND0042200 (Portal Vein Thrombosis)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03193502Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic PVT Compensated CirrhosisTreatment
NCT02627053Treatment of Splanchnic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort StudyTreatment